Sjoukje J C van der Stegen

5PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Electrical energy generation (incl. renewables, excl. photovoltaics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 12, 2024
Author Correction: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells.

Sjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic

|Nov 03, 2022
Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies.

Frank Cichocki, Sjoukje J C van der Stegen, Jeffrey S Miller

|Aug 08, 2022
Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells.

Sjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic

|Jan 14, 2022
HLA-independent T cell receptors for targeting tumors with low antigen density.

Jorge Mansilla-Soto, Justin Eyquem, Sascha Haubner

|May 30, 2018
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade.

Theodoros Giavridis, Sjoukje J C van der Stegen, Justin Eyquem

Pageof 1